Journal Home
Search for

Volume 138, Issue 2, Pages 374-381 (August 2009)


View previous. 21 of 68 View next.

Subtle hemorrhagic brain injury is associated with neurodevelopmental impairment in infants with repaired congenital heart disease

Janet S. Soul, MD, CMafCorresponding Author Informationemail address, Richard L. Robertson, MDbg, David Wypij, PhDchk, David C. Bellinger, PhD, MScaf, Karen J. Visconti, PhDe, Adré J. du Plessis, MBChB, MPHaf, Barry D. Kussman, MBBChdi, Lisa A. Scoppettuolo, MSck, Frank Pigula, MDej, Richard A. Jonas, MDej, Jane W. Newburger, MD, MPHch

Received 1 August 2008; received in revised form 13 November 2008; accepted 9 February 2009. published online 13 April 2009.

Objective

Perioperative stroke and periventricular leukomalacia have been reported to occur commonly in infants with congenital heart disease. We aimed to determine the incidence and type of brain injury in infants undergoing 2-ventricle repair in infancy and to determine risk factors associated with such injury.

Methods

Forty-eight infants enrolled in a trial comparing 2 different hematocrits during surgical repair of congenital heart disease underwent brain magnetic resonance imaging scans and neurodevelopmental testing at 1 year of age.

Results

Eighteen (38%) of our subjects had tiny foci of hemosiderin by susceptibility imaging, without evidence of abnormalities in corresponding regions on conventional magnetic resonance imaging sequences. Subjects with foci of hemosiderin had a significantly lower Psychomotor Developmental Index at 1 year of age (79.6 ± 16.5, mean ± standard deviation) compared with subjects without these foci (89.5 ± 15.3; P = .04). Older age at surgery and diagnostic group were significantly associated with the presence of hemosiderin foci. Only 1 subject had a small stroke (2%), and 2 subjects had periventricular leukomalacia (4%).

Conclusion

Foci of hemosiderin without radiologic evidence of ischemic brain injury are an abnormality associated with adverse neurodevelopmental outcome not previously described in magnetic resonance imaging studies of children with surgically repaired congenital heart disease. The association of hemosiderin foci with older age at surgery and cardiac diagnosis, and not with risk factors associated with brain injury, in previous studies suggests that the cause and pathogenesis of this abnormality are different from ischemic brain lesions reported previously.

CTSNet classification19, 21

a Department of Neurology, at Children's Hospital Boston, Boston, Mass

b Department of Radiology, at Children's Hospital Boston, Boston, Mass

c Department of Cardiology, at Children's Hospital Boston, Boston, Mass

d Department of Anesthesiology, at Children's Hospital Boston, Boston, Mass

e Department of Cardiovascular Surgery, at Children's Hospital Boston, Boston, Mass

f Department of Neurology, at Harvard Medical School, Boston, Mass

g Department of Radiology, at Harvard Medical School, Boston, Mass

h Department of Pediatrics, at Harvard Medical School, Boston, Mass

i Department of Anesthesia, at Harvard Medical School, Boston, Mass

j Department of Surgery, at Harvard Medical School, Boston, Mass

k Department of Biostatistics, Harvard School of Public Health, Boston, Mass

Corresponding Author InformationAddress for reprints: Janet S. Soul, MD, CM, Department of Neurology, Children's Hospital Boston, 300 Longwood Avenue, Boston, MA 02115.

 Supported by grants HL 063411 and RR 02172 from the National Institutes of Health.

 Registered with clinicaltrials.gov (#) NCT00006183.

 Dr Jonas is currently Chief of Cardiovascular Surgery and Co-Director of the Children's National Heart Institute, Washington, DC.

PII: S0022-5223(09)00331-6

doi:10.1016/j.jtcvs.2009.02.027


View previous. 21 of 68 View next.